Navigation Links
Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
Date:10/31/2008

Attributes its 5,000 Percent Revenue Growth from FY03-FY07 to Increased

CyberKnife Acceptance

SUNNYVALE, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), has been named to Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment and Biotechnology companies. This year's Silicon Valley Technology Fast 50 program is co-presented by Deloitte, Silicon Valley Bank, Korn/Ferry International, Cooley Godward Kronish LLP, Cornish & Carey Client Solutions, and ABD Insurance and Financial Services - A Wells Fargo Company. Rankings are based on the percentage revenue growth over five years from fiscal year 2003-2007.

"Deloitte's Silicon Valley Technology Fast 50 companies have shown the strength, vision and tenacity to succeed in today's very competitive technology environment," said Mark Jensen, Managing Partner, National Venture Capital Services, Deloitte & Touche LLP, in Silicon Valley. "We applaud the successes of Accuray Incorporated and acknowledge it as one of the very few to accomplish such a fast growth rate over the past five years."

Accuray Incorporated's 5,000 percent increase in revenues from fiscal year 2003 to 2007 resulted in a fifth place ranking in the Technology Fast 50 for Silicon Valley.

"We are proud of Accuray's consistent growth over the past five years and the impact that the CyberKnife System has had on the cancer community," said Euan S. Thomson, president and chief executive officer of Accuray. "We are honored to be recognized as one of the fastest growing companies in an area as flourishing as the Silicon Valley."

To qualify for the Technology Fast 50, companies must have had operating revenues of at lea
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Accuray Incorporated to Speak at Oppenheimer Healthcare Conference
2. Accuray Incorporated to Report First Quarter Fiscal Year 2009 Financial Results
3. Accuray Incorporated Announces Resignation of Chief Financial Officer
4. Accuray Incorporated to Report Fourth Quarter and Fiscal Year 2008 Financial Results
5. Accuray Incorporateds CEO to Speak at Jefferies Second Annual Healthcare Conference
6. Accuray Incorporateds CEO to Present at Morgan Stanley 2008 Global Healthcare Unplugged Conference
7. Accuray Incorporated to Report Third Quarter Fiscal Year 2008 Financial Results
8. Accurays CFO to Present at B. Riley & Company Ninth Annual Investor Conference
9. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
10. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
11. Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...arkett Sports, the worldwide leader in sports surf...offering with a more complete and innovative range...sports flooring experts and the launch of www.tar...(PRWEB) November 9, 2009 -- Tarkett Sports, redesi... products includes hardwood and synthetic basketba...
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medi...developer, manufacturer and,marketer of medical de...dited,financial results for the third quarter and ...lights for Operations as of September 30, 2009, ...llion, an increase of, 3.1% over the third q...
(Date:11/9/2009)...RNewswire/ -- The Churchill Centre today announc...p to J.W. "Bill" Marriott for his lifelong commitm...e market practices and fostering an open and trans...receive his award at a ceremony and dinner on Tues...ns Hotel. ,, "This is a testament to how Bill ...
(Date:11/9/2009)...nlargement, study finds , , MONDAY, Nov....tor for left atrial enlargement, which increases t...a new study shows. , Atrial fibrillation is the...t rhythm or heartbeat). , Researchers analyzed...rmany who were followed for 10 years. The study au...
(Date:11/9/2009)...t both eye conditions are age-related, researchers... -- Cataract surgery doesn,t appear to speed the p...D), according to a new study that challenges the b...ns the other. , "Because both conditions are st... also have AMD," wrote Li Ming Dong, of Stony Broo...
Breaking Medicine News(10 mins):Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2
...visor and speaker Michael Morgan is helping U.S., ...d Middle Eastern and Islamic investors, business, ...ts tap into one of the most active investment sour...ities for everyone to find new markets, partners a...
...HO: Myles Druckman, MD, a leading disease outbr... Dr. Druckman has been interviewed by, ... CNN, CNBC, and, The Washington Post, a... including:, * The WHO raising ...
...r. Joel Selanikio,s innovative technology is not o...ublic health system around the world. Merging his ...ne and public health with his business partner,s b...lth data in developing nations. Officially establi...
...Biosystems, Inc. (OTC Bulletin Board: WGBS), a lea...s systems, today announced the signing of a resear...nter scientists for WaferGen,s SmartChip(TM) Real-... for Genome Sciences and Policy at Duke Universit...
...n and Narrows Earnings Guidance to Upper End of Ra...Hospira, Inc. (NYSE: HSP ), a leading global spe...any, today reported results for the first quarter ...rtain specified items as described later in this p...
...Associates Outlines China ,s , Stimulus Plan a... has announced a $124 billion stimulus package t... calls for digital hospitalization, adoption of el...tual healthcare services that can help overcome di...
Other Medicine News:Health News:Global Advisor and Speaker Explains Middle East Investors, Politics, Culture 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 3Health News:Open source mobile technology software reinventing health care in developing countries 2Health News:Open source mobile technology software reinventing health care in developing countries 3Health News:Open source mobile technology software reinventing health care in developing countries 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 2Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 3Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 5Health News:Hospira Reports First-Quarter 2009 Results 2Health News:Hospira Reports First-Quarter 2009 Results 3Health News:Hospira Reports First-Quarter 2009 Results 4Health News:Hospira Reports First-Quarter 2009 Results 5Health News:Hospira Reports First-Quarter 2009 Results 6Health News:Hospira Reports First-Quarter 2009 Results 7Health News:Hospira Reports First-Quarter 2009 Results 8Health News:Hospira Reports First-Quarter 2009 Results 9Health News:Hospira Reports First-Quarter 2009 Results 10Health News:Hospira Reports First-Quarter 2009 Results 11Health News:Hospira Reports First-Quarter 2009 Results 12Health News:Hospira Reports First-Quarter 2009 Results 13Health News:Hospira Reports First-Quarter 2009 Results 14Health News:Hospira Reports First-Quarter 2009 Results 15Health News:Hospira Reports First-Quarter 2009 Results 16Health News:Hospira Reports First-Quarter 2009 Results 17Health News:Hospira Reports First-Quarter 2009 Results 18Health News:China Seeks to Transform Healthcare Sector with Information Technology 2
(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...
(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...
(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2Research Councils UK sign groundbreaking MoU with Brazil 9928 1Research Councils UK sign groundbreaking MoU with Brazil 9928 2Research Councils UK sign groundbreaking MoU with Brazil 9928 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5
...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...
... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7
FemoStop
VasoSeal VHD KIT 6
VasoSeal VHD KIT 4
Hemapatch Knitted
Medicine Products: